To the best of our knowledge, this study is the first to explore the effect of EBLN3P on the malignant phenotype of osteosarcoma cells and its molecular mechanism of action, so as to provide a theoretical basis and data supporting EBLN3P as a molecular target for early diagnosis and metastasis control of osteosarcoma. This evidence concerns the gene EBLN3P and osteosarcoma.